Carcinoma Ex Benign Pleomorphic Adenoma of the Parotid Gland
Authors:
- S A. Reza NouraeiSNS A. Reza Nouraei
- Kirsten L. HopeKHKirsten L. Hope
- Charles G. KellyCKCharles G. Kelly
- Neil R. McLeanNMNeil R. McLean
- James V. SoamesJSJames V. Soames
- 1 October 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 116 (5) , 1206-1213
Abstract
Carcinoma in pleomorphic salivary adenoma is a common histologic subtype of primary parotid malignancy. In this study, 28 patients (predominantly male) with histologically diagnosed carcinoma in pleomorphic salivary adenoma presenting over 10 years were retrospectively reviewed. Only 25 percent of patients had a previously treated pleomorphic salivary adenoma. Although the presenting features suggested malignancy in some cases, overall they were nonspecific, overlapping with the presentation of benign disease. Preoperative investigations included fine needle aspiration cytology, which was only 29-percent sensitive, and computed tomography and/or magnetic resonance imaging. There were 14 superficial and 12 total or radical parotidectomies. The facial nerve was resected en bloc with the tumor in nine cases and immediately reconstructed with good reanimation results in patients with recent-onset facial paresis. Only 44 percent of patients had a complete histologic tumor clearance, and this was the most significant determinant of survival (p < 0.01, log-rank analysis). The locoregional control rate was 66 percent at 5 years, but recurrent disease proved invariably fatal. Five-year disease-specific survival was 44 percent with a high rate of disease-specific mortality (87 percent). Carcinoma in pleomorphic salivary adenoma is very difficult to diagnose preoperatively. Fine needle aspiration cytology had a disappointingly low sensitivity for this tumor, potentially misdirecting surgical management. While good locoregional disease control could be achieved with surgery and radiotherapy, carcinoma in pleomorphic salivary adenoma was shown to be aggressive with a high disease-specific rate of mortality. Given that incomplete tumor resection was the most important prognostic factor, a high index of clinical suspicion, radical ablative surgery, and immediate soft-tissue and nerve reconstruction for proven cases are advocated.Keywords
This publication has 25 references indexed in Scilit:
- Clinico-pathological and treatment-related factors influencing survival in parotid cancerBritish Journal of Cancer, 1999
- The development of a prognostic score for patients with parotid carcinomaCancer, 1999
- Malignant tumours of the submandibular salivary gland: a 15-year reviewBritish Journal of Plastic Surgery, 1998
- Malignant tumours of the parotid gland: a 12-year reviewBritish Journal of Plastic Surgery, 1997
- Recurrent Pleomorphic Adenoma of the Parotid Gland: Report of 126 Cases and a Review of the LiteratureAnnals of Otology, Rhinology & Laryngology, 1995
- Parotid masses: Evaluation, analysis, and current managementThe Laryngoscope, 1988
- Surgical Treatment of Recurrent Pleomorphic Adenoma of the Parotid GlandJAMA Otolaryngology–Head & Neck Surgery, 1986
- Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distributionThe Journal of Pathology, 1985
- Malignant Transformation in Concurrent Benign Mixed Tumors of the Parotid and Submaxillary GlandsPlastic and Reconstructive Surgery, 1980
- Malignant mixed tumors arising in salivary glands.I. Carcinomas arising in benign mixed tumors: A clinicopathologic studyCancer, 1977